Fate Therapeutics Inc
Biological Products, (No Diagnostic Substances) · San Diego, CA, United States
- PrincipalsBahram ValamehrPresident and CEOKamal AdawiChief Financial Officerand 1 more
- CompanyFate Therapeutics IncSan Diego, CA, United States
- Phone line+1 (858) 875-1803General business
Fate Therapeutics Inc is an SEC-registered Nasdaq-listed company (ticker FATE) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Chief executive
Bahram ValamehrPresident and CEO
Finance
Kamal AdawiChief Financial Officer
Everyone else on file (1)
Cindy TahlOfficer (see SEC filing)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Bahram Valamehr — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Cindy Tahl — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Kamal Adawi — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Adaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capability